CA2138270A1 - Prosthetic Devices Having Enhanced Osteogenic Properties - Google Patents

Prosthetic Devices Having Enhanced Osteogenic Properties

Info

Publication number
CA2138270A1
CA2138270A1 CA 2138270 CA2138270A CA2138270A1 CA 2138270 A1 CA2138270 A1 CA 2138270A1 CA 2138270 CA2138270 CA 2138270 CA 2138270 A CA2138270 A CA 2138270A CA 2138270 A1 CA2138270 A1 CA 2138270A1
Authority
CA
Canada
Prior art keywords
prosthetic devices
prosthesis
osteogenic properties
enhanced osteogenic
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2138270
Other languages
French (fr)
Other versions
CA2138270C (en
Inventor
David C. Rueger
Thangavel Kuberasampath
Hermann Oppermann
Engin Ozkaynak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stryker Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2138270A1 publication Critical patent/CA2138270A1/en
Application granted granted Critical
Publication of CA2138270C publication Critical patent/CA2138270C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0003—Not used, see subgroups
    • A61C8/0004—Consolidating natural teeth
    • A61C8/0006—Periodontal tissue or bone regeneration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S525/937—Utility as body contact e.g. implant, contact lens or I.U.D.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)

Abstract

A prosthetic device comprising a prosthesis coated with substantially pure osteogenic protein is disclosed. A method for biologically fixing prosthetic devices in vivo is also disclosed. In this method, a prosthesis is implanted in an individual in contact with a substantially pure osteogenic protein, enhancing the strength of the bond between the prosthesis and the existing bone at the joining site.
CA002138270A 1992-06-16 1993-06-08 Prosthetic devices having enhanced osteogenic properties Expired - Lifetime CA2138270C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/901,703 US5344654A (en) 1988-04-08 1992-06-16 Prosthetic devices having enhanced osteogenic properties
US901,703 1992-06-16
PCT/US1993/005446 WO1993025246A1 (en) 1992-06-16 1993-06-08 Prosthetic devices having enhanced osteogenic properties

Publications (2)

Publication Number Publication Date
CA2138270A1 true CA2138270A1 (en) 1993-12-23
CA2138270C CA2138270C (en) 2000-08-08

Family

ID=25414667

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002138270A Expired - Lifetime CA2138270C (en) 1992-06-16 1993-06-08 Prosthetic devices having enhanced osteogenic properties

Country Status (8)

Country Link
US (1) US5344654A (en)
EP (1) EP0646022B1 (en)
JP (1) JP2908563B2 (en)
AT (1) ATE305315T1 (en)
AU (1) AU668411B2 (en)
CA (1) CA2138270C (en)
DE (1) DE69333878T2 (en)
WO (1) WO1993025246A1 (en)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919308B2 (en) * 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
EP1225225A3 (en) * 1988-04-08 2003-01-08 Stryker Corporation Osteogenic devices
US20070166353A1 (en) * 1988-04-08 2007-07-19 Stryker Corporation Osteogenic proteins
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) * 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US20080233170A1 (en) * 1992-02-21 2008-09-25 Stryker Corporation Osteogenic Proteins
US5656297A (en) * 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
US5912015A (en) 1992-03-12 1999-06-15 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
US6074840A (en) 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
CA2551185C (en) 1994-03-28 2007-10-30 Sdgi Holdings, Inc. Apparatus and method for anterior spinal stabilization
US5906827A (en) * 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US5817327A (en) * 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US5591453A (en) * 1994-07-27 1997-01-07 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US5782919A (en) * 1995-03-27 1998-07-21 Sdgi Holdings, Inc. Interbody fusion device and method for restoration of normal spinal anatomy
ES2236792T3 (en) * 1995-03-27 2005-07-16 Sdgi Holdings, Inc. IMPLANTS OF SPINAL FUSION AND INSTRUMENTS FOR INSERTION AND REVIEW.
US6206922B1 (en) 1995-03-27 2001-03-27 Sdgi Holdings, Inc. Methods and instruments for interbody fusion
EP0850051A2 (en) * 1995-08-31 1998-07-01 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
US5989289A (en) 1995-10-16 1999-11-23 Sdgi Holdings, Inc. Bone grafts
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US7026292B1 (en) * 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US20050165483A1 (en) * 2004-01-27 2005-07-28 Ray Eddie F.Iii Bone grafts
JP2000507484A (en) 1996-10-23 2000-06-20 エスディージーアイ・ホールディングス・インコーポレーテッド Spine spacer
CA2280931C (en) * 1997-02-07 2009-05-05 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
US20030153985A1 (en) * 1997-04-26 2003-08-14 Lee Yong Chan Medical implant
KR100237738B1 (en) * 1997-04-26 2000-01-15 이용찬 Implant
US20030032586A1 (en) * 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
EP1007673B1 (en) 1997-07-30 2008-12-17 Emory University Novel bone mineralization proteins, dna, vectors, expression systems
US6214049B1 (en) 1999-01-14 2001-04-10 Comfort Biomedical, Inc. Method and apparatus for augmentating osteointegration of prosthetic implant devices
AU1831999A (en) * 1997-12-18 1999-07-05 Comfort Biomedical, Inc. Bone augmentation for prosthetic implants and the like
US6187329B1 (en) 1997-12-23 2001-02-13 Board Of Regents Of The University Of Texas System Variable permeability bone implants, methods for their preparation and use
US6255359B1 (en) 1997-12-23 2001-07-03 Board Of Regents Of The University Of Texas System Permeable compositions and methods for their preparation
US6428579B1 (en) 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
US6551355B1 (en) * 1998-08-14 2003-04-22 Cambridge Scientific, Inc. Tissue transplant coated with biocompatible biodegradable polymer
DE59903490D1 (en) * 1998-09-11 2003-01-02 Schmidmaier Gerhard BIOLOGICALLY ACTIVE IMPLANTS
DE19906096A1 (en) 1999-02-13 2000-08-17 Walter Sebald Protein with a heparin-binding epitope
US6398808B1 (en) * 1999-06-15 2002-06-04 Scimed Life Systems, Inc. Localized delivery of genetic information from biostable materials
DE19950386A1 (en) * 1999-10-19 2001-05-10 Miladin Lazarov Biocompatible item
JP4777568B2 (en) * 1999-11-11 2011-09-21 株式会社 ジャパン・ティッシュ・エンジニアリング Implant material and method for producing the same
US6368787B1 (en) * 1999-12-16 2002-04-09 Stryker Corporation Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
US6719970B1 (en) 2000-07-10 2004-04-13 Alkermes Controlled Therapeutics, Inc. Method of generating cartilage
ATE296073T1 (en) * 2000-10-11 2005-06-15 Michael D Mason TRANSPLANTLESS SPINE FUSION DEVICE
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US20040131754A1 (en) * 2001-10-24 2004-07-08 Howmedica Osteonics Corp. Antibiotic calcium phosphate coating
BR0214275A (en) * 2001-11-19 2004-09-21 Scil Technology Gmbh Device having osteoconductive and osteoinductive properties
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
ES2260685T3 (en) 2002-09-10 2006-11-01 Scil Technology Gmbh METALLIC IMPLANT COVERED, TO A REDUCED OXYGEN CONCENTRATION, WITH OSTEOINDUCTING PROTEIN.
US7309361B2 (en) * 2002-10-23 2007-12-18 Wasielewski Ray C Biologic modular tibial and femoral component augments for use with total knee arthroplasty
BE1015258A5 (en) 2002-12-18 2004-12-07 Dricot Roland Bone implant.
US9445901B2 (en) * 2003-03-12 2016-09-20 Deger C. Tunc Prosthesis with sustained release analgesic
US7067169B2 (en) * 2003-06-04 2006-06-27 Chemat Technology Inc. Coated implants and methods of coating
ES2569853T3 (en) 2003-06-25 2016-05-12 Biedermann Technologies Gmbh & Co. Kg Tissue integration design for fixing implants without welding
US20070066525A1 (en) * 2004-02-04 2007-03-22 Lee John C Compositions and therapeutic methods using morphogenic proteins
PT1737734E (en) 2004-03-10 2010-11-11 Scil Technology Gmbh Coated implants, their manufacturing and use thereof
KR101013999B1 (en) 2004-03-19 2011-02-14 재단법인서울대학교산학협력재단 Membrane and implant immobilized osteogenic enhancing peptides on the surface
EP2255832A3 (en) 2004-06-16 2011-02-09 Affinergy, Inc. IFBM's to promote attachment of target analytes
WO2006062518A2 (en) 2004-12-08 2006-06-15 Interpore Spine Ltd. Continuous phase composite for musculoskeletal repair
EP1855732A1 (en) * 2005-02-24 2007-11-21 Roland Dricot Bone implant
US8431226B2 (en) * 2005-03-30 2013-04-30 Biomet Manufacturing Corp. Coated medical device
US20060233849A1 (en) * 2005-04-13 2006-10-19 Simon Bruce J Composite bone graft material
US7621963B2 (en) * 2005-04-13 2009-11-24 Ebi, Llc Composite bone graft material
KR101369388B1 (en) 2005-11-14 2014-03-06 바이오메트 쓰리아이 엘엘씨 Deposition of discrete nanoparticles on an implant surface
KR100736826B1 (en) * 2005-12-26 2007-07-09 (주) 코웰메디 Dental implant coat with recombinant human bone morphogenic proteins and Method thereof
US7833270B2 (en) * 2006-05-05 2010-11-16 Warsaw Orthopedic, Inc Implant depots to deliver growth factors to treat osteoporotic bone
US7867061B2 (en) * 2006-09-20 2011-01-11 Mentor Worldwide Llc Texturizing surfaces
WO2008051526A2 (en) * 2006-10-23 2008-05-02 Stryker Corporation Bone morphogenetic proteins
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
PL3345607T3 (en) 2006-12-29 2023-01-09 Ossifi-Mab Llc Methods of altering bone growth by administration of sost or wise antagonist or agonist
US8075562B2 (en) * 2007-06-25 2011-12-13 Wisconsin Alumni Research Foundation Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery
JP2009045142A (en) * 2007-08-16 2009-03-05 Okayama Univ Method of processing base material for inducing bone formation around base material in vivo
ES2545781T3 (en) 2008-01-28 2015-09-15 Biomet 3I, Llc Superficial implant with greater hydrophilicity
US10010500B2 (en) * 2008-08-21 2018-07-03 Biomet Manufacturing, Llc Ceramic implants affording controlled release of active materials
JP2012506733A (en) * 2008-10-24 2012-03-22 ウォーソー・オーソペディック・インコーポレーテッド Compositions and methods for promoting bone formation
PL2435102T3 (en) * 2009-05-28 2021-01-11 Addbio Ab Multilayer protein films, methods of making, and drug delivery devices and biomedical implants employing the films
US8574273B2 (en) 2009-09-09 2013-11-05 Innovision, Inc. Bone screws and methods of use thereof
US11078248B2 (en) 2010-03-19 2021-08-03 Lifenet Health BMP peptides and methods of use
US9809635B2 (en) * 2010-03-19 2017-11-07 Lifenet Health BMP-2 peptides and methods of use
US8641418B2 (en) 2010-03-29 2014-02-04 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
US8809272B2 (en) * 2010-09-09 2014-08-19 The Board Of Trustees Of The Leland Stanford Junior University Use of liposomal Wnt composition to enhance osseointegration
JP2013542837A (en) 2010-11-15 2013-11-28 ジンマー オーソバイオロジクス，インコーポレイティド Bone void filler
US9131995B2 (en) 2012-03-20 2015-09-15 Biomet 3I, Llc Surface treatment for an implant surface
DK2968284T3 (en) 2013-03-14 2021-06-14 Osteoqc Inc ALKYL-AMIN HARMINE DERIVATIVES TO PROMOTE BONE GROWTH
EP2967694B1 (en) 2013-03-15 2022-04-20 INNOVISION, Inc. Bone screws
BR112021002614A2 (en) 2018-08-14 2021-05-04 Osteoqc Inc. pyrrole-dipyridine compounds
CN113166058A (en) 2018-08-14 2021-07-23 奥斯特克有限公司 Fluoro beta-carboline compounds
WO2020118011A1 (en) 2018-12-06 2020-06-11 Alexion Pharmaceuticals, Inc. Anti-alk2 antibodies and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT349129B (en) * 1974-08-12 1979-03-26 Lukesch Friedrich DENTAL PROSTHESIS
US4394370A (en) * 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
CH657266A5 (en) * 1982-10-15 1986-08-29 Sulzer Ag JOINT OPROTHESIS.
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US4620327A (en) * 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction
EP0169001A3 (en) * 1984-07-17 1987-11-25 Collagen Corporation Collagen coated bone implants
US4563350A (en) * 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
IL83003A (en) * 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US5011691A (en) * 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US4968590A (en) * 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
US5108436A (en) * 1988-09-29 1992-04-28 Collagen Corporation Implant fixation
US5207710A (en) * 1988-09-29 1993-05-04 Collagen Corporation Method for improving implant fixation
US5061286A (en) * 1989-08-18 1991-10-29 Osteotech, Inc. Osteoprosthetic implant
ES2118723T3 (en) * 1989-10-17 1998-10-01 Stryker Corp OSTEOGENIC DEVICES.
EP0470305A1 (en) * 1990-08-07 1992-02-12 Osteotech, Inc., Osteoprosthetic implant

Also Published As

Publication number Publication date
ATE305315T1 (en) 2005-10-15
WO1993025246A1 (en) 1993-12-23
DE69333878T2 (en) 2006-07-06
AU4599793A (en) 1994-01-04
AU668411B2 (en) 1996-05-02
CA2138270C (en) 2000-08-08
JPH07504680A (en) 1995-05-25
DE69333878D1 (en) 2006-02-09
US5344654A (en) 1994-09-06
EP0646022B1 (en) 2005-09-28
JP2908563B2 (en) 1999-06-21
EP0646022A1 (en) 1995-04-05

Similar Documents

Publication Publication Date Title
CA2138270A1 (en) Prosthetic Devices Having Enhanced Osteogenic Properties
AU2134397A (en) Prosthetic wrist implants, instruments, and related methods of implantation
AU1702797A (en) Thumb joint prosthesis and related method of implantation
AU3021897A (en) Bone prosthesis fixation device and methods of using same
AU7257196A (en) Artificial ankle joint with cushion structures and prosthetic devices formed therewith
EP1217101B8 (en) Stent with collagen
AU5173200A (en) Proximal femoral replacement implant and method of implanting the same
EP0910999A3 (en) Modular prosthesis system with hybrid fixation
AU1831999A (en) Bone augmentation for prosthetic implants and the like
UA32519C2 (en) Artificial joint for orthopedic prostheses and orthesis
AU7133298A (en) Implantable medical device and method of manufacture
AU7909691A (en) Surgical implant and method incorporating chemotherapeutic agents
AU2777399A (en) Bone prosthesis and method of implantation
GB2323036B (en) Prosthetic implant and surgical tool
EP0678285A3 (en) Orthopaedic implant and method of making same.
HK1012588A1 (en) Filling material for soft tissue implant prostheses and implants made therewith
AU2676795A (en) Soft implantable surgical prosthesis for increasing or restoring the volume of soft tissues, in particular a breast prosthesis and method of manufacture
EP1201204A3 (en) Apparatus and method for securing soft tissue to an artificial prosthesis
AU2040400A (en) Bone graft and guided bone regeneration method
AU3981397A (en) System for diagnosis, placement and prosthetic restoration of root form implant
AU4513397A (en) Hip joint prosthesis
YU97402A (en) Transcutaneous prothesis
AU7574691A (en) Method and device for efficiently anchoring an implant, and method and device for promoting growth of bone tissue
AU3258195A (en) Artificial joint, in particular artificial human hip joint
AU6073094A (en) Holding means and method of implantation of osseous tissue

Legal Events

Date Code Title Description
EEER Examination request